Search Orphan Drug Designations and Approvals
-
Generic Name: | (9-[N-(3-morpholinopropyl)-sulfonyl]-5,6-dihydro-5-oxo-11-H-indeno [1,2-c] isoquinoline methanesulfonic acid |
---|---|
Date Designated: | 12/08/2004 |
Orphan Designation: | Prevention of post-operative complications of aortic anuerysm surgical repair |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Inotek Pharmaceuticals Corporation 100 Cummings Center Beverly, Massachusetts 01915 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-